AgroFresh Solutions (AGFS) 10-Q 7 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Oct. 25, 2019
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2019
Document Transition Report	false
Entity File Number	001-36316
Entity Registrant Name	AgroFresh Solutions, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-4007249
Entity Address, Address Line One	510-530 Walnut Street, Suite 1350
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19106
City Area Code	267
Local Phone Number	317-9139
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,957,878
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001592016
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AGFS
Security Exchange Name	NASDAQ
Warrants
Entity Information [Line Items]
Title of 12(b) Security	Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
Trading Symbol	AGFSW
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 18,746	$ 34,852
Accounts receivable, net of allowance for doubtful accounts of $2,358 and $2,336, respectively	72,074	67,942
Inventories	24,199	24,807
Other current assets	14,648	15,608
Total Current Assets	129,667	143,209
Property and equipment, net	13,643	13,289
Goodwill	6,091	6,670
Intangible assets, net	676,938	711,967
Deferred income tax assets	10,095	7,332
Other assets	22,492	16,820
TOTAL ASSETS	858,926	899,287
Current Liabilities:
Accounts payable	10,257	7,530
Current portion of long-term debt	4,748	6,419
Income taxes payable	4,374	4,815
Accrued expenses and other current liabilities	41,397	45,340
Total Current Liabilities	60,776	64,104
Long-term debt	398,619	400,309
Other noncurrent liabilities	40,733	32,066
Deferred income tax liabilities	17,555	30,232
Total liabilities	517,683	526,711
Commitments and contingencies (see Note 19)
Stockholders’ Equity:
Common stock, par value $0.0001; 400,000,000 shares authorized, 51,592,959 and 51,071,573 shares issued and 50,931,578 and 50,410,192 outstanding at September 30, 2019 and December 31, 2018, respectively	5	5
Preferred stock; par value $0.0001, 1 share authorized and outstanding	0	0
Treasury stock; par value $0.0001, 661,381 shares at September 30, 2019 and December 31, 2018, respectively	(3,885)	(3,885)
Additional paid-in capital	538,075	535,819
Accumulated deficit	(170,388)	(138,789)
Accumulated other comprehensive loss	(30,491)	(28,837)
Total AgroFresh Stockholders’ Equity	333,316	364,313
Non-controlling interest	7,927	8,263
Total Stockholders' Equity	341,243	372,576
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 858,926	$ 899,287
Par value of common stock (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Treasury stock (in shares)	661,381	661,381

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Allowance for doubtful accounts	$ 2,358	$ 2,336
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	51,592,959	51,071,573
Common stock, shares outstanding (in shares)	50,931,578	50,410,192
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares outstanding (in shares)	1	1
Treasury stock (in shares)	661,381	661,381
Treasury Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net sales	$ 48,972	$ 68,698	$ 109,095	$ 125,470
Cost of sales (excluding amortization, shown separately below)	13,892	16,662	31,516	32,910
Gross profit	35,080	52,036	77,579	92,560
Research and development expenses	2,566	3,491	9,720	10,293
Selling, general, and administrative expenses	14,998	18,212	47,044	50,133
Amortization of intangibles	11,754	12,002	35,136	34,342
Impairment of long lived assets	0	0	992	0
Change in fair value of contingent consideration	(229)	307	128	543
Operating income (loss)	5,991	18,024	(15,441)	(2,751)
Other (expense) income	(81)	(189)	(119)	419
Gain (loss) on foreign currency exchange	54	(4,731)	(2,884)	472
Interest expense, net	(8,606)	(9,132)	(26,021)	(26,250)
(Loss) income before income taxes	(2,642)	3,972	(44,465)	(28,110)
Income taxes (benefit) expense	(5,653)	1,018	(12,530)	214
Net income (loss) including non-controlling interests	3,011	2,954	(31,935)	(28,324)
Less: Net loss attributable to non-controlling interests	(278)	(516)	(336)	(442)
Net income (loss) attributable to AgroFresh Solutions, Inc	$ 3,289	$ 3,470	$ (31,599)	$ (27,882)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.06	$ 0.06	$ (0.64)	$ (0.57)
Diluted (in dollars per share)	$ 0.06	$ 0.06	$ (0.64)	$ (0.57)
Weighted average shares outstanding:
Basic (in shares)	50,227,590	49,853,181	50,138,835	49,671,648
Diluted (in shares)	50,288,304	50,309,979	50,138,835	49,671,648

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 3,011	$ 2,954	$ (31,935)	$ (28,324)
Other comprehensive (loss) income:
Unrealized gain on hedging activity, net of tax of $24, $158, $24 and $989, respectively	83		83
Unrealized gain on hedging activity, net of tax of $24, $158, $24 and $989, respectively		558		3,509
Recognition of gain on hedging activity reclassified to net loss, net of tax of $78 and $235, respectively	(278)		(834)
Recognition of gain on hedging activity reclassified to net loss, net of tax of $78 and $235, respectively		0		0
Foreign currency translation adjustments	(3,823)	(11,088)	(903)	(24,123)
Comprehensive loss	$ (1,007)	$ (7,576)	$ (33,589)	$ (48,938)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Unrealized gain on hedging activity, tax	$ 24	$ 24
Unrealized gain on hedging activity, tax			$ 158	$ 989
Realized gain on hedging activity reclassified to net loss, tax	$ 78	$ 235

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Non-Controlling Interest
Balances - beginning at Dec. 31, 2017	$ 416,080	$ 0	$ 5	$ (3,885)	$ 533,015	$ (108,729)	$ (12,769)	$ 8,443
Balances - beginning (in shares) at Dec. 31, 2017		1	51,002,234
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	2,028				2,028
Issuance of stock, net of forfeitures (in shares)			98,357
Comprehensive income (loss)	(48,938)					(27,882)	(20,614)	(442)
Balances - ending at Sep. 30, 2018	369,170	$ 0	$ 5	(3,885)	535,043	(136,611)	(33,383)	8,001
Balances - ending (in shares) at Sep. 30, 2018		1	51,100,591
Balances - beginning at Jun. 30, 2018	376,477	$ 0	$ 5	(3,885)	534,774	(140,099)	(22,834)	8,516
Balances - beginning (in shares) at Jun. 30, 2018		1	51,148,343
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	269				269
Issuance of stock, net of forfeitures (in shares)			(47,752)
Comprehensive income (loss)	(7,576)					3,488	(10,549)	(515)
Balances - ending at Sep. 30, 2018	369,170	$ 0	$ 5	(3,885)	535,043	(136,611)	(33,383)	8,001
Balances - ending (in shares) at Sep. 30, 2018		1	51,100,591
Balances - beginning at Dec. 31, 2018	372,576	$ 0	$ 5	(3,885)	535,819	(138,789)	(28,837)	8,263
Balances - beginning (in shares) at Dec. 31, 2018		1	51,071,573
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	2,256				2,256
Issuance of stock, net of forfeitures (in shares)			521,386
Comprehensive income (loss)	(33,589)					(31,599)	(1,654)	(336)
Balances - ending at Sep. 30, 2019	341,243	$ 0	$ 5	(3,885)	538,075	(170,388)	(30,491)	7,927
Balances - ending (in shares) at Sep. 30, 2019		1	51,592,959
Balances - beginning at Jun. 30, 2019	341,434	$ 0	$ 5	(3,885)	537,259	(173,677)	(26,473)	8,205
Balances - beginning (in shares) at Jun. 30, 2019		1	51,620,770
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	816				816
Issuance of stock, net of forfeitures (in shares)			(27,811)
Comprehensive income (loss)	(1,007)					3,289	(4,018)	(278)
Balances - ending at Sep. 30, 2019	$ 341,243	$ 0	$ 5	$ (3,885)	$ 538,075	$ (170,388)	$ (30,491)	$ 7,927
Balances - ending (in shares) at Sep. 30, 2019		1	51,592,959

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (31,935)	$ (28,324)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	36,692	35,486
Provision for bad debts	215	599
Stock-based compensation	2,256	1,965
Pension expense	0	71
Impairment of intangible assets	992	0
Amortization of deferred financing costs	2,032	1,842
Interest income on interest rate swap	(1,070)	4,041
Accretion of contingent consideration	2,669	2,894
Change in fair value of contingent consideration	128	543
Deferred income taxes	(14,499)	(97)
Loss on sales of property	2	0
Other	0	81
Changes in operating assets and liabilities:
Accounts receivable	(1,499)	(30,124)
Inventories	(4,424)	260
Prepaid expenses and other current assets	(1,429)	(4,137)
Accounts payable	3,855	(7,208)
Accrued expenses and other liabilities	(2,958)	7,115
Income taxes payable	(95)	(1,467)
Other assets and liabilities	384	245
Net cash used in operating activities	(8,684)	(16,215)
Cash flows from investing activities:
Cash paid for property and equipment	(3,271)	(3,179)
Asset acquisition	0	(1,587)
Other investments	(250)	0
Net cash used in investing activities	(3,521)	(4,766)
Cash flows from financing activities:
Payment of Dow liabilities settlement	0	(10,000)
Repayment of long-term debt	(5,056)	(3,517)
Net cash used in financing activities	(5,056)	(13,517)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	1,682	(4,013)
Net decrease in cash and cash equivalents and restricted cash	(15,579)	(38,511)
Cash and cash equivalents and restricted cash, beginning of period	34,852	64,533
Cash and cash equivalents and restricted cash, end of period	19,273	26,022
Cash paid for:
Cash paid for interest	18,007	23,280
Cash paid for income taxes	2,469	5,304
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	62	316
Right of use assets obtained in exchange for new lease liabilities	376	0
Reconciliation of cash and cash equivalents and restricted cash:
Total cash and cash equivalents and restricted cash	$ 34,852	$ 64,533

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business AgroFresh Solutions, Inc. (the “Company”) is a global leader in delivering innovative food preservation and waste reduction solutions for fresh produce. The Company is empowering the food industry with Smarter Freshness TM , a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. The Company’s solutions range from near-harvest with Harvista TM and LandSpring TM , to its marquee SmartFresh TM Quality System, which includes SmartFresh TM , FreshCloud TM and ActiMist TM , working together to maintain the quality of stored produce. The Company has a controlling interest in Tecnidex Fruit Protection, S.A.U. (“Tecnidex”), a leading provider of post-harvest fungicides, waxes, and sanitizers for the citrus market. Additionally, the Company’s initial retail solution, RipeLock TM , optimizes banana ripening for the benefit of retailers and consumers. The Company has key products registered in over 50 countries, supports approximately 3,900 direct customers and services over 25,000 storage rooms globally. The end markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples, the Company’s primary market, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the apple growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere. The Company was originally incorporated as Boulevard Acquisition Corp. (“Boulevard”), a blank check company, in Delaware on October 24, 2013, and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. On July 31, 2015, the Company completed a Business Combination (refer to Note 3) and changed its name to AgroFresh Solutions, Inc. Prior to consummation of the Business Combination, the Company’s efforts were limited to organizational activities, its initial public offering and related financings, and the search for suitable business acquisition transactions.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2018. Adoption of Highly Inflationary Accounting in Argentina GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company has been closely monitoring the inflation data and currency volatility in Argentina, where there are multiple data sources for measuring and reporting inflation. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company has elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. Under highly inflationary accounting, the functional currency of the Company's subsidiary in Argentina became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on Argentine peso-denominated monetary assets and liabilities will be reflected in earnings. As of September 30, 2019, the Company’s subsidiary in Argentina had a net asset position of $6.7 million. Net sales attributable to Argentina were approximately 6% and 5% of the Company’s consolidated net sales for the nine months ended September 30, 2019 and 2018, respectively. Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 19,726 $ 22,377 $ 1,680 $ 1,605 $ 45,388 Fungicides, waxes, coatings, sanitizers — 2,857 198 — 3,055 Other* 218 86 108 117 529 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Pattern of Revenue Recognition Products transferred at a point in time $ 19,802 $ 25,238 $ 1,877 $ 1,605 $ 48,522 Services transferred over time 142 82 109 117 450 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Revenues for the three months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 26,029 $ 34,284 $ 779 $ 2,387 $ 63,479 Fungicides, waxes, coatings, sanitizers 270 4,047 — — 4,317 Other* 614 134 154 — 902 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Pattern of Revenue Recognition Products transferred at a point in time $ 26,774 $ 38,342 $ 907 $ 2,176 $ 68,199 Services transferred over time 139 123 26 211 499 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Revenues for the nine months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 23,084 $ 31,965 $ 27,503 $ 11,287 $ 93,839 Fungicides, waxes, coatings, sanitizers — 11,365 1,458 — 12,823 Other* 954 927 381 171 2,433 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Pattern of Revenue Recognition Products transferred at a point in time $ 23,380 $ 43,374 $ 29,159 $ 11,309 $ 107,222 Services transferred over time 658 883 183 149 1,873 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Revenues for the nine months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 28,378 $ 43,508 $ 26,185 $ 12,228 $ 110,299 Fungicides, waxes, coatings, biocides 270 12,981 — — 13,251 Other* 1,236 349 335 — 1,920 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 Pattern of Revenue Recognition Products and equipment transferred at a point in time $ 29,701 $ 56,658 $ 26,448 $ 11,784 $ 124,591 Services transferred over time 183 180 72 444 879 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 *Other includes FreshCloud, technical services and sales-type leases related to Tecnidex. ——————————————————————————————— (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East, and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru, and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan, and Thailand. Contract Assets and Liabilities ASC 606 requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g. receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2019 and the twelve months ended December 31, 2018: (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 1,956 $ 8,958 $ (6,911) $ 4,003 Contract liabilities: Deferred revenue $ 1,280 $ 2,810 $ (2,761) $ 1,329 (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 739 $ 7,117 $ (5,900) $ 1,956 Contract liabilities: Deferred revenue $ 100 $ 4,428 $ (3,248) $ 1,280 The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company generally receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the three months ended September 30, 2019. Amounts reclassified from unbilled revenue to accounts receivable for the nine months ended September 30, 2019 and for the year ended December 31, 2018 were $6.9 million and $5.9 million, respectively. Amounts reclassified from deferred revenue to revenue for the nine months ended September 30, 2019 and the year ended December 31, 2018 were $2.8 million and $3.2 million, respectively. Recently Issued Accounting Standards and Pronouncements In August 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-12 Targeted Improvements to Accounting for Hedging Activities. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted upon its issuance. The Company adopted the new ASU as of January 1, 2019 and it did not have a material impact on the Company's financial statements. In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation, Scope of Modification Accounting . ASU 2017-09 addresses the changes to the terms and conditions of share-based awards. ASU 2017-09 is effective for periods beginning after December 15, 2017 and interim periods therein on a modified retrospective basis. The Company adopted the new ASU as of January 1, 2018, and it did not have a material impact on the financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations, Clarifying the Definition of a Business . The new accounting guidance clarifies the definition of a business and provides additional guidance to assist entities with evaluating whether transactions should be accounted for as asset acquisitions (or asset disposals) or business combinations (or disposals of a business). Under the new guidance, an entity first determines whether substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this criterion is met, the transaction should be accounted for as an asset acquisition as opposed to a business combination. This distinction is important because the accounting for an asset acquisition significantly differs from the accounting for a business combination. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. During the second quarter of 2018, the Company adopted this standard in connection with the acquisition of Verigo (refer to Note 3). In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other, which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. Early adoption is permitted for interim or annual goodwill impairments tests after January 1, 2017. This standard will impact future financial statements when adopted if the Company has impairment to its goodwill. In February 2016, the FASB issued ASU 2016-02, Leases . The main objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including

Business Combinations and Asset

Business Combinations and Asset Acquisition	9 Months Ended
	Sep. 30, 2019
Business Combinations [Abstract]
Business Combinations and Asset Acquisition	Business Combinations and Asset Acquisition Business Combination with Dow On July 31, 2015 (the "Closing Date"), the Company consummated a business combination (the “Business Combination”) pursuant to the Stock Purchase Agreement, dated April 30, 2015 (the “Purchase Agreement”), by and between the Company and The Dow Chemical Company ("Dow") providing for the acquisition by the Company of the AgroFresh business from Dow, resulting in AgroFresh Inc. becoming a wholly-owned, indirect subsidiary of the Company. Pursuant to the Purchase Agreement, the Company paid the following consideration to Rohm and Haas Company (“R&H”), a subsidiary of Dow: (i) 17.5 million shares of common stock and (ii) $635 million in cash. Pursuant to a Tax Receivables Agreement among the Company, Dow, R&H and AgroFresh Inc. entered into in connection with the consummation of the Business Combination, as amended on April 4, 2017 (as so amended, the “Tax Receivables Agreement”), the Company is required to pay to Dow 50% of the annual tax savings, if any, in U.S. federal, state and local income tax or franchise tax that the Company actually realizes as a result of the increase in tax basis of the AgroFresh assets resulting from a Section 338(h)(10) election that the Company and Dow made in connection with the Business Combination. On April 4, 2017, the Company entered into an agreement (the “Amendment Agreement”) with Dow, R&H, Boulevard Acquisition Sponsor, LLC (the “Sponsor”) and certain other parties. Pursuant to the Amendment Agreement, among other things, the Company agreed to pay Dow the aggregate amount of $20.0 million, of which $10.0 million was paid on April 4, 2017 and the remaining $10.0 million was paid on January 31, 2018, in full satisfaction of the Company’s obligations with respect to (i) the working capital adjustment under the Purchase Agreement, (ii) certain transfer and value added tax reimbursement obligations under the Purchase Agreement, and (iii) the amount payable to Dow pursuant to the Tax Receivables Agreement on account of the 2015 tax year. During the three months ended March 31, 2018, these liabilities were extinguished. Acquisition of Tecnidex On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling interest in Tecnidex. The transaction was closed on December 1, 2017. Tecnidex is a leading provider of post-harvest fungicides, waxes, coatings, and sanitizers for the citrus market, with clients in 18 countries. For over 35 years, Tecnidex has been helping fruit and vegetable producers offer clean, safe and high-quality products to their regional clients. The acquisition was accounted for as a purchase in accordance with ASC 805, Business Combination . At the effective date of the acquisition, the Company agreed to pay holders of Tecnidex an estimated $25.0 million in cash for 75% of the outstanding capital stock, of which $20.0 million was paid on December 1, 2017. In 2018, the purchase price was finalized as $22.3 million after giving effect to working capital, net debt and other adjustments. The remaining $2.3 million was paid during 2018. In accordance with the acquisition method of accounting, the Company has allocated the purchase price to the estimated fair values of the identifiable assets acquired and liabilities assumed, with any excess allocated to goodwill. The preliminary assessment of fair value of the contingent consideration payments on the acquisition date was approximately $0.7 million and was estimated by applying a probability-based income approach utilizing an appropriate discount rate. This estimation was based on significant inputs that are not observable in the market, referred to as Level 3 inputs. During 2018 there was an adjustment made to consideration payable to holders of Tecnidex which resulted in a measurement period adjustment of $2.8 million to the purchase price allocation. Acquisition of Verigo On April 9, 2018, the Company acquired the assets of Comm-n-Sense Corp., d/b/a Verigo ("Verigo"), pursuant to the terms of an Asset Purchase Agreement, for approximately $1.8 million. Verigo, a privately-held organization, provided hardware in the form of wireless data receptors along with cloud-based software to synchronize data pulled from the hardware to support and provide tools for monitoring environmental and quality factors, such as temperature and relative humidity. The transaction was accounted for as an asset acquisition because substantially all of the fair value of the gross assets acquired was concentrated in a single asset, the acquired software. Asset acquisitions are accounted for using a cost accumulation approach, whereby the total consideration paid is allocated to the individual assets acquired and liabilities assumed on a relative fair value basis.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Company is a party to ongoing agreements with Dow, a related party, including, but not limited to, operating-related agreements for certain transition services. In connection with the Transition Services Agreement, the Company paid Dow a $5.0 million set-up fee which was amortized over the period during which the services were expected to be provided. The Company incurred expenses for such services for the nine months ended September 30, 2019 and September 30, 2018 as follows: (in thousands) Nine Months Ended September 30, 2019 Nine Months Ended September 30, 2018 Ongoing costs of transition services agreement $ 90 $ 251 Other expenses — 1,484 Total incurred expenses $ 90 $ 1,735 As of September 30, 2019 and September 30, 2018, the Company had an outstanding payable to Dow of $0.1 million and $0.5 million, respectively, related to the Transition Services Agreement. Refer to Note 3 During 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser, a director of the Company. In February 2019, the Company made a further minority investment in RipeLocker. On November 29, 2016, the Company entered into a Mutual Services Agreement (the “Services Agreement”) with George Lobisser and RipeLocker. Pursuant to the Services Agreement, (i) the Company agreed to provide RipeLocker with technical support, in the form of access to the Company’s research and development personnel for a specified number of hours for purposes of providing advice and input relating to RipeLocker’s products and services, and (ii) Mr. Lobisser agreed to provide consulting services to the Company as may be reasonably requested by the Company from time to time. The Services Agreement provided for Mr. Lobisser to receive a consulting fee of $5,000 per full day for time spent performing consulting services under the Services Agreement (pro-rated for any partial day), plus reimbursement for out-of-pocket expenses, provided that for each hour of technical support provided by the Company to RipeLocker, Mr. Lobisser agreed to provide one-half hour of consulting services for no consideration. In February 2017, the Company and Mr. Lobisser agreed to substantially curtail any mutual consulting services to be provided under the Services Agreement, and that any further services would be provided at no charge. For the nine months ended September 30, 2019 and 2018, there were no material amounts paid and as of September 30, 2019, there were no material amounts owed to RipeLocker or Mr. Lobisser for consulting services.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Inventories	InventoriesInventories at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Raw material $ 2,852 $ 1,286 Work-in-process 4,996 4,749 Finished goods 15,306 17,535 Supplies 1,045 1,237 Total inventories $ 24,199 $ 24,807

Other Current Assets

Other Current Assets	9 Months Ended
	Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Other Current Assets The Company's other current assets at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, VAT receivable $ 6,531 $ 7,854 Prepaid income tax asset 4,813 5,090 Prepaid and other current assets 3,304 2,664 Total other current assets $ 14,648 $ 15,608

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands, except for useful life data) Useful life September 30, December 31, Buildings and leasehold improvements 7-20 $ 6,030 $ 4,647 Machinery & equipment 1-12 10,487 8,193 Furniture 1-12 2,656 2,712 Construction in progress 1,701 1,744 20,874 17,296 Less: accumulated depreciation (7,231) (4,007) Total property and equipment, net $ 13,643 $ 13,289 Depreciation expense was $0.6 million and $0.4 million for the three months ended September 30, 2019 and 2018, respectively, and $1.6 million and $1.2 million, for the nine months ended September 30, 2019 and 2018, respectively. Depreciation expense is recorded in cost of sales, selling, general and administrative expense and research and development expense in the condensed consolidated statements of operations.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Changes in the carrying amount of goodwill for the nine months ended September 30, 2019 and the twelve months ended December 31, 2018 were as follows: (in thousands) September 30, December 31, Balance as of Beginning balance $ 6,670 $ 9,402 Measurement period adjustment — (2,807) Foreign currency translation (579) 75 Balance as of Ending balance $ 6,091 $ 6,670 See Note 3 for a description of the measurement period adjustment. The Company’s intangible assets at September 30, 2019 and December 31, 2018 consisted of the following: September 30, 2019 December 31, 2018 (in thousands) Gross Carrying Accumulated Impairment Net Gross Carrying Accumulated Impairment Net Other intangible assets: Developed technology $ 759,205 $ (165,730) $ — $ 593,475 $ 759,290 $ (134,151) $ — $ 625,139 In-process research and development 39,000 (6,681) — 32,319 39,000 (5,055) — 33,945 Trade name 27,216 — — 27,216 28,507 — (2,600) 25,907 Service provider network 2,000 — — 2,000 2,000 — — 2,000 Customer relationships 17,866 (1,958) — 15,908 19,872 (2,198) — 17,674 Software 10,604 (3,638) (992) 5,974 9,405 (2,161) — 7,244 Other 100 (54) — 46 100 (42) — 58 Total intangible assets $ 855,991 $ (178,061) $ (992) $ 676,938 $ 858,174 $ (143,607) $ (2,600) $ 711,967 During the Company's annual impairment testing conducted for the year ended December 31, 2018, the Company recorded an impairment charge of $2.6 million on its SmartFresh trade name. During the nine months ended September 30, 2019, the Company had an impairment charge of $1.0 million associated with the Verigo software following a partnership agreement with a new technology provider. At September 30, 2019, the weighted-average amortization periods remaining for developed technology, in-process R&D, customer relationships, software and other was 15.6, 13.0, 15.0, 3.0, and 2.8 years, respectively. At September 30, 2019, the weighted-average amortization period remaining for these finite-lived intangible assets was 15.4 years. Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2019 is as follows: (in thousands) Amount 2019 (remaining) $ 10,893 2020 43,545 2021 43,295 2022 43,150 2023 43,142 Thereafter 463,697 Total $ 647,722 Amortization expense for intangible assets was $11.8 million and $12.0 million for the three months ended September 30, 2019 and 2018, respectively, and $35.1 million and $34.3 million, for the nine months ended September 30, 2019 and 2018, respectively.

Accrued and Other Current Liabi

Accrued and Other Current Liabilities	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
Accrued and Other Current Liabilities	Accrued and Other Current LiabilitiesThe Company’s accrued and other current liabilities at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Tax amortization benefit contingency $ 10,844 $ 11,098 Additional consideration due seller 451 379 Accrued compensation and benefits 9,136 10,192 Accrued rebates payable 4,302 3,616 Insurance premium financing payable 1,247 721 Severance 638 971 Deferred revenue 1,329 1,280 Accrued taxes 4,030 5,316 Accrued interest 5,086 — Lease liability 1,534 — Other 2,800 11,767 Total accrued and other current liabilities $ 41,397 $ 45,340

Debt

Debt	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Debt	Debt The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Total Term Loan outstanding $ 406,937 $ 410,125 Unamortized deferred issuance costs (4,474) (6,168) Tecnidex loan outstanding 904 2,771 Less: Amounts due within one year 4,748 6,419 Total long-term debt due after one year $ 398,619 $ 400,309 At September 30, 2019, the Company evaluated the amount recorded under the Term Loan (defined below) and determined that the fair value was approximately $376.4 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy. The Term Loan is presented net of deferred issuance costs, which are amortized using the effective interest method over the term of the Term Loan. Gross deferred issuance costs at the inception of the Term Loan were $12.9 million and as of September 30, 2019 there were $4.5 million of unamortized deferred issuance costs. Scheduled principal repayments of debt subsequent to September 30, 2019 are as follows: (in thousands) Amount 2019 (remaining) $ 1,213 2020 4,792 2021 401,836 Total $ 407,841 Credit Facility On July 31, 2015, in connection with the consummation of the Business Combination, AgroFresh Inc. as the borrower and its parent, AF Solutions Holdings LLC (“AF Solutions Holdings”), a wholly-owned subsidiary of the Company, as the guarantor, entered into a Credit Agreement with Bank of Montreal, as administrative agent (as subsequently amended, the “Credit Facility”). The Credit Facility consists of a $425.0 million term loan (the “Term Loan”), with an amortization equal to 1.00% per year, and a revolving loan facility (the “Revolving Loan”). On January 31, 2019, the Revolving Loan was amended to reduce the total availability from $25.0 million to $12.5 million, to extend the maturity date from July 31, 2019 to December 31, 2020, and to amend certain financial covenants. The Revolving Loan includes a $10.0 million letter-of-credit sub-facility, issuances against which reduce the available capacity for borrowing. The Term Loan has a scheduled maturity date of July 31, 2021. The interest rates on borrowings under the facilities are either the alternate base rate plus 3.75% or LIBOR plus 4.75% per annum, with a 1.00% LIBOR floor (with step-downs in respect of borrowings under the Revolving Loan dependent upon the achievement of certain financial ratios). The obligations under the Credit Facility are secured by liens on substantially all of the assets of (a) AgroFresh Inc. and its direct wholly-owned domestic subsidiaries, and (b) AF Solutions Holdings, including the common stock of AgroFresh Inc. The net proceeds of the Term Loan were used to fund a portion of the purchase price payable to Dow in connection with the Business Combination. Amounts available under the Revolving Loan may also be used for working capital, general corporate purposes, and other uses, all as more fully set forth in the Credit Agreement. At September 30, 2019, there was $406.9 million outstanding under the Term Loan and no balance outstanding under the Revolving Loan. As of the Closing Date, the Company incurred approximately $12.9 million in debt issuance costs related to the Term Loan and $1.3 million in costs related to the Revolving Loan. The debt issuance costs associated with the Term Loan were capitalized against the principal balance of the debt, and the Revolving Loan costs were capitalized in Other Assets. All issuance costs will be accreted through interest expense for the duration of each respective debt facility. The interest expense related to the amortization of the debt issuance costs during the three and nine months ended September 30, 2019 was approximately $0.6 million and $1.7 million, respectively. The interest expense related to the amortization of the debt issuance costs during the three and nine months ended September 30, 2018 was approximately $0.6 million and $1.8 million, respectively. Certain restrictive covenants are contained in the Credit Facility, which includes the Revolving Loan, and the Company was in compliance with these covenants as of September 30, 2019. The Company had full availability to draw under the Revolving Loan as of September 30, 2019. The Company entered into an interest rate swap contract in August 2019 to hedge interest rate risk associated with the Term Loan. During the three months ended September 30, 2019, an unrealized gain of $0.1 million was recognized in connection with this swap. The interest rate swap contract matures on December 31, 2020. Beginning with the year ended December 31, 2016, the Company is required to prepay Term Loan Borrowings and Incremental Term Loan Borrowings in an aggregate amount equal to 50% of the "Excess Cash Flow" (as defined in the Credit Facility) for the fiscal year; provided that such amount of the Excess Cash Flow in any fiscal year shall be reduced by (i) the aggregate amount of prepayments of Term Loans and Incremental Term Loans made, (ii) to the extent accompanied by permanent reductions of Revolving Commitments, the aggregate amount of prepayments of Revolving Loans (other than prepayments financed with the proceeds of Indebtedness), and (iii) repaid borrowings of Revolving Loans made on the Effective Date to account for any additional original issue discount or upfront fees that are implemented pursuant to the Fee Letter provided further that, prepayments of Term Loan Borrowings and Incremental Term Loan Borrowings shall only be required if 50% of the Excess Cash Flow for such fiscal year exceeds $5.0 million. There are no amounts due under this provision as of September 30, 2019.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Leases	Leases The Company enters into lease agreements for certain facilities and vehicles that are primarily used in the ordinary course of business. These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Most leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. The Company, in determining the present value of lease payments, utilizes either the rate implicit in the lease if that rate is readily determinable or the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease. Lease expense is primarily included in general and administrative expenses in the condensed consolidated statements of operations. Additional information regarding the Company's operating leases is as follows: (in thousands) Three Months Ended September 30, 2019 Nine Months Ended Operating Lease Cost Operating leases $ 591 $ 1,849 Short-term leases (1) 5 52 Total lease expense $ 596 $ 1,901 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases Cash payments included in operating cash flows $ 1,625 Weighted average discount rate 9.33 % Weighted average remaining lease term in years 5.53 The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2019: (in thousands) Lease Liability Remainder of 2019 $ 540 2020 1,905 2021 1,641 2022 1,487 2023 1,277 2024 and thereafter 2,364 Total undiscounted lease payments $ 9,214 Less: present value adjustment 2,075 Operating lease liability $ 7,139 The following table presents the future minimum lease payments as of December 31, 2018 under noncancellable operating leases: (in thousands) Future lease Payments 2019 $ 3,413 2020 2,058 2021 1,790 2022 1,640 2023 1,242 Thereafter 2,396 Total $ 12,539

Other Noncurrent Liabilities

Other Noncurrent Liabilities	9 Months Ended
	Sep. 30, 2019
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Other Noncurrent Liabilities	Other Noncurrent Liabilities The Company’s other noncurrent liabilities at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Tax amortization benefit contingency $ 32,363 $ 29,369 Lease liability 5,605 — Other (1) 2,765 2,697 Total other noncurrent liabilities $ 40,733 $ 32,066

Severance

Severance	9 Months Ended
	Sep. 30, 2019
Compensation Related Costs [Abstract]
Severance	SeveranceSeverance expense was $0.3 million and $1.7 million for the three months ended September 30, 2019 and 2018, respectively, and $1.0 million and $2.1 million for the nine months ended September 30, 2019 and 2018, respectively. This amount, which does not include stock compensation expense, was recorded in selling, general and administrative expense in the condensed consolidated statements of loss. As of September 30, 2019 and December 31, 2018, the Company had a $0.6 million and $1.0 million severance liability, respectively.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2019
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders’ Equity The authorized common stock of the Company consists of 400,000,000 shares with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2019, there were 50,931,578 shares of common stock outstanding. As of September 30, 2019, there were warrants to purchase 15,983,072 shares of the Company’s common stock outstanding at a strike price of $11.50. Of the 15,983,072 warrants, 9,823,072 were issued as part of the units sold in the Company's initial public offering in February 2014 (1,201,928 warrants were subsequently repurchased during 2015) and 6,160,000 warrants were sold in a private placement at the time of such public offering. In connection with and as a condition to the consummation of the Business Combination, the Company issued Dow one share of Series A Preferred Stock. Dow, voting as a separate class, is entitled to appoint one director to the Company’s board of directors for so long as Dow beneficially holds 10% or more of the aggregate amount of the outstanding shares of common stock and non-voting common stock of the Company. The Series A Preferred Stock has no other rights.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation In July 2015, the Company adopted the 2015 Incentive Compensation Plan (as amended, the “Plan”), pursuant to which the Compensation Committee of the Company is authorized to grant up to 7,150,000 shares to officers and employees of the Company, in the form of equity-based awards, including time or performance based options and restricted stock. In June 2019, the Company's shareholders approved the 2019 Employee Stock Purchase Plan (the "ESPP"), which was effective July 1, 2019. 500,000 shares of common stock are reserved for issuance under the ESPP. As of September 30, 2019, no shares had been issued under the ESPP. Stock compensation expense for equity-classified and liability-classified awards for the three and nine months ended September 30, 2019 was $1.0 million and $2.1 million, respectively. Stock compensation expense for equity-classified and liability-classified awards for the three and nine months ended September 30, 2018 was $0.2 million and $2.0 million, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses, and research and development expenses. At September 30, 2019, there was $4.4 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of 1.8 years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company had a loss for the nine months ended September 30, 2019 and 2018. Therefore, the effect of stock-based awards including options, restricted stock, restricted stock units, and warrants outstanding at September 30, 2019 and September 30, 2018, respectively, have not been included in the computation of diluted loss per share because their inclusion would have been anti-dilutive. The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net income (loss) per common share: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Basic weighted-average common shares outstanding 50,227,590 49,853,181 50,138,835 49,671,648 Effect of dilutive options, performance stock units and restricted stock 60,714 456,798 — — Diluted weighted-average shares outstanding 50,288,304 50,309,979 50,138,835 49,671,648 Securities that could potentially be dilutive are excluded from the computation of diluted earnings (loss) per share when a loss from continuing operations exists, when the exercise price exceeds the average closing price of the Company's common stock during the period, or for contingently issued shares, if the contingency is not met at the end of the reporting period, because their inclusion would result in an anti-dilutive effect on per share amounts. The following represent the number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Stock-based compensation awards (1) : Stock options 1,028,583 322,158 949,987 322,158 Restricted stock to non-directors 749,510 336,286 624,930 278,289 Restricted stock to directors — 84,427 — 72,655 Warrants: Private placement warrants 6,160,000 6,160,000 6,160,000 6,160,000 Public warrants 9,823,072 9,823,072 9,823,072 9,823,072 (1) SARs and Phantom Shares are payable in cash so will have no impact on number of shares

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The provision for income taxes consists of provisions for federal, state, and foreign incomes taxes. The effective tax rates for the periods ended September 30, 2019, and September 30, 2018, reflect the Company’s expected tax rate on reported income from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates. On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was enacted in the U.S. The TCJA represents sweeping changes in U.S. tax law. Among other changes in tax law, the TCJA permanently reduced the U.S. corporate income tax rate to 21% beginning in 2018, imposed a one-time repatriation tax on deferred foreign earnings, established a participation exemption system by allowing a 100% dividends received deduction on qualifying dividends paid by foreign subsidiaries, limited deductions for net interest expense, and expanded the U.S. taxation of foreign earned income to include “global intangible low-taxed income” (“GILTI”). The Company's effective tax rate for the three and nine months ended September 30, 2019 was 214.0% and 28.2%, respectively, compared to the effective tax rate for the three and nine months ended September 30, 2018 of 25.6% and (0.8)%, respectively.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Segment Information	Segment InformationThe authoritative guidance for disclosures about segments of an enterprise establishes standards for reporting information about segments. It defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker in deciding how to allocate resources and in assessing performance. We currently operate and manage our business as two operating segments. Our chief operating decision-makers allocate resources and assess performance of the business for each segment. Accordingly, we consider ourselves to have two operating and reportable segments (i) AgroFresh core and (ii) Tecnidex. AgroFresh core business is providing produce preservation and waste reduction solutions for growers and packers. Its products include SmartFresh, Harvista, RipeLock and FreshCloud. Tecnidex is a provider of fungicides, sanitizers, waxes, and coatings primarily focused on the citrus market. Our chief operating decision-makers do not evaluate operating segments using asset or liability information. The following table presents a breakdown of our revenues and gross profit based on reportable segments for the three and nine months ended September 30, 2019 and 2018. (in thousands) Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended AgroFresh Core Revenues $ 45,917 $ 64,647 $ 96,272 $ 112,489 Gross Profit 34,182 51,149 72,679 87,861 Tecnidex Revenues 3,055 4,051 12,823 12,981 Gross Profit 898 887 4,900 4,699 Total Revenues $ 48,972 $ 68,698 $ 109,095 $ 125,470 Total Gross Profit $ 35,080 $ 52,036 $ 77,579 $ 92,560

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations. On October 14, 2019, the Company was awarded a verdict of $31.1 million in damages, related to, among other things, trade secret misappropriation and willful patent infringement, in its litigation against Decco Post-Harvest, Inc. ("Decco") and Decco's parent company, UPL Limited. The award is subject to post-verdict review by the Court and any appeals that may be taken by the parties in the future. Purchase Commitments The Company has various purchasing contracts for contract manufacturing and research and development services which are based on the requirements of the business. Generally, the contracts are at prices not in excess of current market prices and do not commit the business to obligations outside the normal customary terms for similar contracts.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Liabilities Measured at Fair Value on a Recurring Basis The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of September 30, 2019: (in thousands) Level 1 Level 2 Level 3 Total Tax amortization benefit contingency (1) $ — $ — $ 43,207 $ 43,207 Contingent consideration (2) — — 451 451 Liability-classified stock compensation (3) — — 218 218 Interest rate swap (4) $ — $ (106) $ — $ (106) Total $ — $ (106) $ 43,876 $ 43,770 The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2018: (in thousands) Level 1 Level 2 Level 3 Total Tax amortization benefit contingency (1) $ — $ — $ 40,467 $ 40,467 Contingent consideration (2) — — 379 379 Liability-classified stock compensation (3) — — 550 550 Total $ — $ — $ 41,396 $ 41,396 (1) The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, using an estimated tax rate of 21.5% and discounted to present value utilizing an appropriate market discount rate. (2) The fair value of the contingent consideration related to the Tecnidex acquisition. (3) The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the nine months ended September 30, 2019. The fair value of time based phantom shares is based on the fair value of the Company's common stock. The fair value of performance based phantom shares was measured using a Monte Carlo pricing model during the nine months ended September 30, 2019. The valuation technique used did not change during the nine months ended September 30, 2019. (4) The derivative assets and liabilities relate to an interest rate derivative that is measured at fair value using observable market inputs such as interest rates, our own credit risks as well as an evaluation of the counterparts' credit risks. There were no transfers between Level 1 and Level 2 and no transfers out of Level 3 of the fair value hierarchy during the nine months ended September 30, 2019. At September 30, 2019, the Company evaluated the amount recorded under the Term Loan and determined that the fair value was approximately $376.4 million. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value. Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis The following table presents the changes during the period presented in our Level 3 financial instrument liabilities that are measured at fair value on a recurring basis. (in thousands) Tax amortization benefit contingency Contingent consideration related to acquisition Liability-classified stock compensation Interest rate swap Total Balance, December 31, 2018 $ 40,467 $ 379 $ 550 $ — $ 41,396 Accretion 2,669 — — — 2,669 Tecnidex earnout activity — 72 — — 72 Stock compensation activity — — (332) — (332) Mark-to-market adjustment 71 — — (106) (35) Balance, September 30, 2019 $ 43,207 $ 451 $ 218 $ (106) $ 43,770

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2018.
Revenue Recognition	Adoption of Highly Inflationary Accounting in Argentina GAAP requires the use of highly inflationary accounting for countries whose cumulative three-year inflation rate exceeds 100 percent. The Company has been closely monitoring the inflation data and currency volatility in Argentina, where there are multiple data sources for measuring and reporting inflation. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company has elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. Under highly inflationary accounting, the functional currency of the Company's subsidiary in Argentina became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on Argentine peso-denominated monetary assets and liabilities will be reflected in earnings. As of September 30, 2019, the Company’s subsidiary in Argentina had a net asset position of $6.7 million. Net sales attributable to Argentina were approximately 6% and 5% of the Company’s consolidated net sales for the nine months ended September 30, 2019 and 2018, respectively. Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues for the three months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 19,726 $ 22,377 $ 1,680 $ 1,605 $ 45,388 Fungicides, waxes, coatings, sanitizers — 2,857 198 — 3,055 Other* 218 86 108 117 529 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Pattern of Revenue Recognition Products transferred at a point in time $ 19,802 $ 25,238 $ 1,877 $ 1,605 $ 48,522 Services transferred over time 142 82 109 117 450 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Revenues for the three months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 26,029 $ 34,284 $ 779 $ 2,387 $ 63,479 Fungicides, waxes, coatings, sanitizers 270 4,047 — — 4,317 Other* 614 134 154 — 902 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Pattern of Revenue Recognition Products transferred at a point in time $ 26,774 $ 38,342 $ 907 $ 2,176 $ 68,199 Services transferred over time 139 123 26 211 499 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Revenues for the nine months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 23,084 $ 31,965 $ 27,503 $ 11,287 $ 93,839 Fungicides, waxes, coatings, sanitizers — 11,365 1,458 — 12,823 Other* 954 927 381 171 2,433 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Pattern of Revenue Recognition Products transferred at a point in time $ 23,380 $ 43,374 $ 29,159 $ 11,309 $ 107,222 Services transferred over time 658 883 183 149 1,873 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Revenues for the nine months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 28,378 $ 43,508 $ 26,185 $ 12,228 $ 110,299 Fungicides, waxes, coatings, biocides 270 12,981 — — 13,251 Other* 1,236 349 335 — 1,920 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 Pattern of Revenue Recognition Products and equipment transferred at a point in time $ 29,701 $ 56,658 $ 26,448 $ 11,784 $ 124,591 Services transferred over time 183 180 72 444 879 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 *Other includes FreshCloud, technical services and sales-type leases related to Tecnidex. ——————————————————————————————— (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East, and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru, and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan, and Thailand. Contract Assets and Liabilities ASC 606 requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g. receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2019 and the twelve months ended December 31, 2018: (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 1,956 $ 8,958 $ (6,911) $ 4,003 Contract liabilities: Deferred revenue $ 1,280 $ 2,810 $ (2,761) $ 1,329 (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 739 $ 7,117 $ (5,900) $ 1,956 Contract liabilities: Deferred revenue $ 100 $ 4,428 $ (3,248) $ 1,280
Recently Issued Accounting Standards and Pronouncements	Recently Issued Accounting Standards and Pronouncements In August 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-12 Targeted Improvements to Accounting for Hedging Activities. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. This update will be effective for the Company for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted upon its issuance. The Company adopted the new ASU as of January 1, 2019 and it did not have a material impact on the Company's financial statements. In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation, Scope of Modification Accounting . ASU 2017-09 addresses the changes to the terms and conditions of share-based awards. ASU 2017-09 is effective for periods beginning after December 15, 2017 and interim periods therein on a modified retrospective basis. The Company adopted the new ASU as of January 1, 2018, and it did not have a material impact on the financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations, Clarifying the Definition of a Business . The new accounting guidance clarifies the definition of a business and provides additional guidance to assist entities with evaluating whether transactions should be accounted for as asset acquisitions (or asset disposals) or business combinations (or disposals of a business). Under the new guidance, an entity first determines whether substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this criterion is met, the transaction should be accounted for as an asset acquisition as opposed to a business combination. This distinction is important because the accounting for an asset acquisition significantly differs from the accounting for a business combination. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. During the second quarter of 2018, the Company adopted this standard in connection with the acquisition of Verigo (refer to Note 3). In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other, which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. Early adoption is permitted for interim or annual goodwill impairments tests after January 1, 2017. This standard will impact future financial statements when adopted if the Company has impairment to its goodwill. In February 2016, the FASB issued ASU 2016-02, Leases . The main objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Schedule of disaggregated revenue	Revenues for the three months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 19,726 $ 22,377 $ 1,680 $ 1,605 $ 45,388 Fungicides, waxes, coatings, sanitizers — 2,857 198 — 3,055 Other* 218 86 108 117 529 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Pattern of Revenue Recognition Products transferred at a point in time $ 19,802 $ 25,238 $ 1,877 $ 1,605 $ 48,522 Services transferred over time 142 82 109 117 450 $ 19,944 $ 25,320 $ 1,986 $ 1,722 $ 48,972 Revenues for the three months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 26,029 $ 34,284 $ 779 $ 2,387 $ 63,479 Fungicides, waxes, coatings, sanitizers 270 4,047 — — 4,317 Other* 614 134 154 — 902 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Pattern of Revenue Recognition Products transferred at a point in time $ 26,774 $ 38,342 $ 907 $ 2,176 $ 68,199 Services transferred over time 139 123 26 211 499 $ 26,913 $ 38,465 $ 933 $ 2,387 $ 68,698 Revenues for the nine months ended September 30, 2019 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 23,084 $ 31,965 $ 27,503 $ 11,287 $ 93,839 Fungicides, waxes, coatings, sanitizers — 11,365 1,458 — 12,823 Other* 954 927 381 171 2,433 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Pattern of Revenue Recognition Products transferred at a point in time $ 23,380 $ 43,374 $ 29,159 $ 11,309 $ 107,222 Services transferred over time 658 883 183 149 1,873 $ 24,038 $ 44,257 $ 29,342 $ 11,458 $ 109,095 Revenues for the nine months ended September 30, 2018 (in thousands) Region North America EMEA Latin America Asia Pacific (4) Total Revenue Product 1-MCP based $ 28,378 $ 43,508 $ 26,185 $ 12,228 $ 110,299 Fungicides, waxes, coatings, biocides 270 12,981 — — 13,251 Other* 1,236 349 335 — 1,920 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 Pattern of Revenue Recognition Products and equipment transferred at a point in time $ 29,701 $ 56,658 $ 26,448 $ 11,784 $ 124,591 Services transferred over time 183 180 72 444 879 $ 29,884 $ 56,838 $ 26,520 $ 12,228 $ 125,470 *Other includes FreshCloud, technical services and sales-type leases related to Tecnidex. ——————————————————————————————— (1) North America includes the United States and Canada. (2) EMEA includes Europe, the Middle East, and Africa. (3) Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru, and Uruguay. (4) Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan, and Thailand.
Schedule of changes in contract assets and liabilities	The following table presents changes in the Company’s contract assets and liabilities during the nine months ended September 30, 2019 and the twelve months ended December 31, 2018: (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 1,956 $ 8,958 $ (6,911) $ 4,003 Contract liabilities: Deferred revenue $ 1,280 $ 2,810 $ (2,761) $ 1,329 (in thousands) Balance at Additions Deductions Balance at, Contract assets: Unbilled revenue $ 739 $ 7,117 $ (5,900) $ 1,956 Contract liabilities: Deferred revenue $ 100 $ 4,428 $ (3,248) $ 1,280

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Schedule of incurred expenses for services	The Company incurred expenses for such services for the nine months ended September 30, 2019 and September 30, 2018 as follows: (in thousands) Nine Months Ended September 30, 2019 Nine Months Ended September 30, 2018 Ongoing costs of transition services agreement $ 90 $ 251 Other expenses — 1,484 Total incurred expenses $ 90 $ 1,735

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Raw material $ 2,852 $ 1,286 Work-in-process 4,996 4,749 Finished goods 15,306 17,535 Supplies 1,045 1,237 Total inventories $ 24,199 $ 24,807

Other Current Assets (Tables)

Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of other current assets	The Company's other current assets at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, VAT receivable $ 6,531 $ 7,854 Prepaid income tax asset 4,813 5,090 Prepaid and other current assets 3,304 2,664 Total other current assets $ 14,648 $ 15,608

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands, except for useful life data) Useful life September 30, December 31, Buildings and leasehold improvements 7-20 $ 6,030 $ 4,647 Machinery & equipment 1-12 10,487 8,193 Furniture 1-12 2,656 2,712 Construction in progress 1,701 1,744 20,874 17,296 Less: accumulated depreciation (7,231) (4,007) Total property and equipment, net $ 13,643 $ 13,289

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	Changes in the carrying amount of goodwill for the nine months ended September 30, 2019 and the twelve months ended December 31, 2018 were as follows: (in thousands) September 30, December 31, Balance as of Beginning balance $ 6,670 $ 9,402 Measurement period adjustment — (2,807) Foreign currency translation (579) 75 Balance as of Ending balance $ 6,091 $ 6,670
Schedule of other intangible assets	The Company’s intangible assets at September 30, 2019 and December 31, 2018 consisted of the following: September 30, 2019 December 31, 2018 (in thousands) Gross Carrying Accumulated Impairment Net Gross Carrying Accumulated Impairment Net Other intangible assets: Developed technology $ 759,205 $ (165,730) $ — $ 593,475 $ 759,290 $ (134,151) $ — $ 625,139 In-process research and development 39,000 (6,681) — 32,319 39,000 (5,055) — 33,945 Trade name 27,216 — — 27,216 28,507 — (2,600) 25,907 Service provider network 2,000 — — 2,000 2,000 — — 2,000 Customer relationships 17,866 (1,958) — 15,908 19,872 (2,198) — 17,674 Software 10,604 (3,638) (992) 5,974 9,405 (2,161) — 7,244 Other 100 (54) — 46 100 (42) — 58 Total intangible assets $ 855,991 $ (178,061) $ (992) $ 676,938 $ 858,174 $ (143,607) $ (2,600) $ 711,967
Schedule of estimated annual amortization expense for finite-lived intangible assets	Estimated annual amortization expense for finite-lived intangible assets subsequent to September 30, 2019 is as follows: (in thousands) Amount 2019 (remaining) $ 10,893 2020 43,545 2021 43,295 2022 43,150 2023 43,142 Thereafter 463,697 Total $ 647,722

Accrued and Other Current Lia_2

Accrued and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
Accrued and other current liabilities	The Company’s accrued and other current liabilities at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Tax amortization benefit contingency $ 10,844 $ 11,098 Additional consideration due seller 451 379 Accrued compensation and benefits 9,136 10,192 Accrued rebates payable 4,302 3,616 Insurance premium financing payable 1,247 721 Severance 638 971 Deferred revenue 1,329 1,280 Accrued taxes 4,030 5,316 Accrued interest 5,086 — Lease liability 1,534 — Other 2,800 11,767 Total accrued and other current liabilities $ 41,397 $ 45,340

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of debt, net of unamortized discount and deferred financing fees	The Company’s debt, net of unamortized deferred issuance costs, at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Total Term Loan outstanding $ 406,937 $ 410,125 Unamortized deferred issuance costs (4,474) (6,168) Tecnidex loan outstanding 904 2,771 Less: Amounts due within one year 4,748 6,419 Total long-term debt due after one year $ 398,619 $ 400,309
Schedule of principal repayments under the term loan	Scheduled principal repayments of debt subsequent to September 30, 2019 are as follows: (in thousands) Amount 2019 (remaining) $ 1,213 2020 4,792 2021 401,836 Total $ 407,841

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of Additional Information of Operating Leases	Additional information regarding the Company's operating leases is as follows: (in thousands) Three Months Ended September 30, 2019 Nine Months Ended Operating Lease Cost Operating leases $ 591 $ 1,849 Short-term leases (1) 5 52 Total lease expense $ 596 $ 1,901 (1) Leases with an initial term of twelve months or less are not recorded on the balance sheet. Other information on operating leases Cash payments included in operating cash flows $ 1,625 Weighted average discount rate 9.33 % Weighted average remaining lease term in years 5.53
Schedule of Maturities of Lease Liabilities	The following table presents the contractual maturities of the Company's lease liabilities as of September 30, 2019: (in thousands) Lease Liability Remainder of 2019 $ 540 2020 1,905 2021 1,641 2022 1,487 2023 1,277 2024 and thereafter 2,364 Total undiscounted lease payments $ 9,214 Less: present value adjustment 2,075 Operating lease liability $ 7,139
Schedule of Future Minimum Lease Payments	The following table presents the future minimum lease payments as of December 31, 2018 under noncancellable operating leases: (in thousands) Future lease Payments 2019 $ 3,413 2020 2,058 2021 1,790 2022 1,640 2023 1,242 Thereafter 2,396 Total $ 12,539

Other Noncurrent Liabilities (T

Other Noncurrent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2019
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Other noncurrent liabilities	The Company’s other noncurrent liabilities at September 30, 2019 and December 31, 2018 consisted of the following: (in thousands) September 30, December 31, Tax amortization benefit contingency $ 32,363 $ 29,369 Lease liability 5,605 — Other (1) 2,765 2,697 Total other noncurrent liabilities $ 40,733 $ 32,066

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Schedule of weighted average common shares outstanding	The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net income (loss) per common share: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Basic weighted-average common shares outstanding 50,227,590 49,853,181 50,138,835 49,671,648 Effect of dilutive options, performance stock units and restricted stock 60,714 456,798 — — Diluted weighted-average shares outstanding 50,288,304 50,309,979 50,138,835 49,671,648
Amounts that could potentially dilute basic earnings per share	The following represent the number of shares that could potentially dilute basic earnings per share in the future: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Stock-based compensation awards (1) : Stock options 1,028,583 322,158 949,987 322,158 Restricted stock to non-directors 749,510 336,286 624,930 278,289 Restricted stock to directors — 84,427 — 72,655 Warrants: Private placement warrants 6,160,000 6,160,000 6,160,000 6,160,000 Public warrants 9,823,072 9,823,072 9,823,072 9,823,072 (1) SARs and Phantom Shares are payable in cash so will have no impact on number of shares

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Schedule of revenue by segment	The following table presents a breakdown of our revenues and gross profit based on reportable segments for the three and nine months ended September 30, 2019 and 2018. (in thousands) Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended AgroFresh Core Revenues $ 45,917 $ 64,647 $ 96,272 $ 112,489 Gross Profit 34,182 51,149 72,679 87,861 Tecnidex Revenues 3,055 4,051 12,823 12,981 Gross Profit 898 887 4,900 4,699 Total Revenues $ 48,972 $ 68,698 $ 109,095 $ 125,470 Total Gross Profit $ 35,080 $ 52,036 $ 77,579 $ 92,560

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Tabular disclosure of financial instruments measured at fair value on a recurring basis	The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of September 30, 2019: (in thousands) Level 1 Level 2 Level 3 Total Tax amortization benefit contingency (1) $ — $ — $ 43,207 $ 43,207 Contingent consideration (2) — — 451 451 Liability-classified stock compensation (3) — — 218 218 Interest rate swap (4) $ — $ (106) $ — $ (106) Total $ — $ (106) $ 43,876 $ 43,770 The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2018: (in thousands) Level 1 Level 2 Level 3 Total Tax amortization benefit contingency (1) $ — $ — $ 40,467 $ 40,467 Contingent consideration (2) — — 379 379 Liability-classified stock compensation (3) — — 550 550 Total $ — $ — $ 41,396 $ 41,396 (1) The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, using an estimated tax rate of 21.5% and discounted to present value utilizing an appropriate market discount rate. (2) The fair value of the contingent consideration related to the Tecnidex acquisition. (3) The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the nine months ended September 30, 2019. The fair value of time based phantom shares is based on the fair value of the Company's common stock. The fair value of performance based phantom shares was measured using a Monte Carlo pricing model during the nine months ended September 30, 2019. The valuation technique used did not change during the nine months ended September 30, 2019.
Changes in financial instruments measured at level 3 fair value on a recurring basis	The following table presents the changes during the period presented in our Level 3 financial instrument liabilities that are measured at fair value on a recurring basis. (in thousands) Tax amortization benefit contingency Contingent consideration related to acquisition Liability-classified stock compensation Interest rate swap Total Balance, December 31, 2018 $ 40,467 $ 379 $ 550 $ — $ 41,396 Accretion 2,669 — — — 2,669 Tecnidex earnout activity — 72 — — 72 Stock compensation activity — — (332) — (332) Mark-to-market adjustment 71 — — (106) (35) Balance, September 30, 2019 $ 43,207 $ 451 $ 218 $ (106) $ 43,770

Description of Business (Detail

Description of Business (Details) storage_room in Thousands	9 Months Ended
	Sep. 30, 2019storage_roomcountrycustomer
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating countries (over) | country	50
Number of customers | customer	3,900
Number of service locations (more than) | storage_room	25

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Jan. 01, 2019
Concentration Risk [Line Items]
Lease liability	$ 7,139
ARGENTINA | Subsidiaries
Concentration Risk [Line Items]
Net assets	$ 6,700
Sales Revenue, Net | Geographic Concentration Risk | ARGENTINA
Concentration Risk [Line Items]
Concentration risk percentage	6.00%	5.00%
Accounting Standards Update 2016-02
Concentration Risk [Line Items]
Right-of-use asset			$ 7,300
Lease liability			$ 7,300

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Total Revenue	$ 48,972	$ 68,698	$ 109,095	$ 125,470
North America
Disaggregation of Revenue [Line Items]
Total Revenue	19,944	26,913	24,038	29,884
EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	25,320	38,465	44,257	56,838
Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	1,986	933	29,342	26,520
Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	1,722	2,387	11,458	12,228
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Total Revenue	48,522	68,199	107,222	124,591
Products transferred at a point in time | North America
Disaggregation of Revenue [Line Items]
Total Revenue	19,802	26,774	23,380	29,701
Products transferred at a point in time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	25,238	38,342	43,374	56,658
Products transferred at a point in time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	1,877	907	29,159	26,448
Products transferred at a point in time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	1,605	2,176	11,309	11,784
Services transferred over time
Disaggregation of Revenue [Line Items]
Total Revenue	450	499	1,873	879
Services transferred over time | North America
Disaggregation of Revenue [Line Items]
Total Revenue	142	139	658	183
Services transferred over time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	82	123	883	180
Services transferred over time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	109	26	183	72
Services transferred over time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	117	211	149	444
1-MCP based
Disaggregation of Revenue [Line Items]
Total Revenue	45,388	63,479	93,839	110,299
1-MCP based | North America
Disaggregation of Revenue [Line Items]
Total Revenue	19,726	26,029	23,084	28,378
1-MCP based | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	22,377	34,284	31,965	43,508
1-MCP based | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	1,680	779	27,503	26,185
1-MCP based | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	1,605	2,387	11,287	12,228
Fungicides, waxes, coatings, sanitizers
Disaggregation of Revenue [Line Items]
Total Revenue	3,055	4,317	12,823	13,251
Fungicides, waxes, coatings, sanitizers | North America
Disaggregation of Revenue [Line Items]
Total Revenue	0	270	0	270
Fungicides, waxes, coatings, sanitizers | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	2,857	4,047	11,365	12,981
Fungicides, waxes, coatings, sanitizers | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	198	0	1,458	0
Fungicides, waxes, coatings, sanitizers | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	0	0	0	0
Other
Disaggregation of Revenue [Line Items]
Total Revenue	529	902	2,433	1,920
Other | North America
Disaggregation of Revenue [Line Items]
Total Revenue	218	614	954	1,236
Other | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	86	134	927	349
Other | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	108	154	381	335
Other | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	$ 117	$ 0	$ 171	$ 0

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Contract assets:
Beginning balance	$ 1,956	$ 739
Additions	8,958	7,117
Deductions	(6,911)
Ending balance	4,003	1,956
Contract liabilities:
Beginning balance	1,280	100
Additions	2,810	4,428
Deductions	(2,761)	(3,248)
Ending balance	1,329	1,280
Amounts reclassified from unbilled revenue to accounts receivable	6,900	5,900
Amounts reclassified from deferred revenue to revenue	$ 2,800	$ 3,200

Business Combinations and Ass_2

Business Combinations and Asset Acquisition (Details) $ in Thousands	Apr. 09, 2018USD ($)	Jan. 31, 2018USD ($)	Dec. 01, 2017USD ($)	Apr. 04, 2017USD ($)	Jul. 31, 2015USD ($)shares	Dec. 31, 2018USD ($)	Sep. 30, 2019country	Nov. 07, 2017country
Class of Warrant or Right [Line Items]
Number of operating countries | country							50
Verigo
Class of Warrant or Right [Line Items]
Payments to acquire software	$ 1,800
Tax receivables agreement (TRA) | Dow
Class of Warrant or Right [Line Items]
Rate of tax receivable agreement				50.00%
Amendment agreement | Dow
Class of Warrant or Right [Line Items]
Increase (decrease) in liabilities				$ 20,000
Cash paid to related party		$ 10,000		$ 10,000
AgroFresh Inc.
Class of Warrant or Right [Line Items]
Cash consideration					$ 635,000
Tecnidex Fruit Protection, S.A.U.
Class of Warrant or Right [Line Items]
Cash consideration			$ 20,000			$ 2,300
Purchase price			$ 25,000			22,300
Percentage of voting interests acquired			75.00%
Common Stock | AgroFresh Inc.
Class of Warrant or Right [Line Items]
Number of shares issued as consideration (in shares) | shares					17,500,000
Level 3 | Tecnidex Fruit Protection, S.A.U.
Class of Warrant or Right [Line Items]
Contingent consideration			$ 700
Adjustment to purchase price allocation						$ 2,800
Tecnidex Fruit Protection, S.A.U. | Tecnidex Fruit Protection, S.A.U.
Class of Warrant or Right [Line Items]
Number of operating countries | country								18

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Nov. 29, 2016
Dow
Related party transactions
Outstanding payable to related party	$ 100,000	$ 500,000
Amounts owed to related parties for consulting services	(100,000)	(500,000)
Director | Mutal services agreement
Related party transactions
Outstanding payable to related party	0
Consulting fee, daily			$ 5,000
Expenses paid per service agreement	0	0
Amounts owed to related parties for consulting services	0
Dow | Seperate IT Services
Related party transactions
Payment amount for services	5,000,000
Dow | Dow
Related party transactions
Payment amount for services	90,000	1,735,000
Dow | Dow | Ongoing costs of transition services agreement
Related party transactions
Payment amount for services	90,000	251,000
Dow | Dow | Other expenses
Related party transactions
Payment amount for services	$ 0	$ 1,484,000

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw material	$ 2,852	$ 1,286
Work-in-process	4,996	4,749
Finished goods	15,306	17,535
Supplies	1,045	1,237
Total inventories	$ 24,199	$ 24,807

Other Current Assets (Details)

Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
VAT receivable	$ 6,531	$ 7,854
Prepaid income tax asset	4,813	5,090
Prepaid and other current assets	3,304	2,664
Total other current assets	$ 14,648	$ 15,608

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 20,874		$ 20,874		$ 17,296
Less: accumulated depreciation	(7,231)		(7,231)		(4,007)
Total property and equipment, net	13,643		13,643		13,289
Depreciation expense	600	$ 400	1,600	$ 1,200
Buildings and lease hold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,030		$ 6,030		4,647
Buildings and lease hold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			7 years
Buildings and lease hold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			20 years
Machinery & equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	10,487		$ 10,487		8,193
Machinery & equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Machinery & equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Furniture
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,656		$ 2,656		2,712
Furniture | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)			1 year
Furniture | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)			12 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,701		$ 1,701		$ 1,744

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Goodwill [Roll Forward]
Beginning balance	$ 6,670	$ 9,402
Measurement period adjustment	0	(2,807)
Foreign currency translation	(579)	$ 75
Ending balance	$ 6,091

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Other intangible assets:
Total intangible assets	$ 855,991	$ 858,174
Accumulated Amortization	(178,061)	(143,607)
Impairment	(992)	(2,600)
Net, finite-lived intangible assets	647,722
Total intangible assets, net	$ 676,938	711,967
Weighted average
Other intangible assets:
Useful life	15 years 4 months 24 days
Trade name
Other intangible assets:
Gross carrying amount, indefinite-lived	$ 27,216	28,507
Impairment		(2,600)
Net, indefinite-lived intangible assets	27,216	25,907
Impairment charge		2,600
Service provider network
Other intangible assets:
Gross carrying amount, indefinite-lived	2,000	2,000
Net, indefinite-lived intangible assets	2,000	2,000
Developed technology
Other intangible assets:
Gross carrying amount, finite-lived	759,205	759,290
Accumulated Amortization	(165,730)	(134,151)
Net, finite-lived intangible assets	$ 593,475	625,139
Developed technology | Weighted average
Other intangible assets:
Useful life	15 years 7 months 6 days
In-process research and development
Other intangible assets:
Gross carrying amount, finite-lived	$ 39,000	39,000
Accumulated Amortization	(6,681)	(5,055)
Net, finite-lived intangible assets	$ 32,319	33,945
In-process research and development | Weighted average
Other intangible assets:
Useful life	15 years
Customer relationships
Other intangible assets:
Gross carrying amount, finite-lived	$ 17,866	19,872
Accumulated Amortization	(1,958)	(2,198)
Net, finite-lived intangible assets	$ 15,908	17,674
Customer relationships | Weighted average
Other intangible assets:
Useful life	13 years
Software
Other intangible assets:
Gross carrying amount, finite-lived	$ 10,604	9,405
Accumulated Amortization	(3,638)	(2,161)
Impairment	(992)
Net, finite-lived intangible assets	$ 5,974	7,244
Software | Weighted average
Other intangible assets:
Useful life	3 years
Other
Other intangible assets:
Gross carrying amount, finite-lived	$ 100	100
Accumulated Amortization	(54)	(42)
Net, finite-lived intangible assets	$ 46	$ 58
Other | Weighted average
Other intangible assets:
Useful life	2 years 9 months 18 days

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Future Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Estimated annual amortization expense
2019 (remaining)	$ 10,893		$ 10,893
2020	43,545		43,545
2021	43,295		43,295
2022	43,150		43,150
2023	43,142		43,142
Thereafter	463,697		463,697
Net, finite-lived intangible assets	647,722		647,722
Amortization of intangibles	$ 11,754	$ 12,002	$ 35,136	$ 34,342

Accrued and Other Current Lia_3

Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Tax amortization benefit contingency	$ 10,844	$ 11,098
Additional consideration due seller	451	379
Accrued compensation and benefits	9,136	10,192
Accrued rebates payable	4,302	3,616
Insurance premium financing payable	1,247	721
Severance	638	971
Deferred revenue	1,329	1,280
Accrued taxes	4,030	5,316
Accrued interest	5,086	0
Lease liability	1,534	0
Other	2,800	11,767
Total accrued and other current liabilities	$ 41,397	$ 45,340

Debt - Net of Unamortized Disco

Debt - Net of Unamortized Discounts and Deferred Financing Fees (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Less: Amounts due within one year	$ 4,748	$ 6,419
Long-term debt	398,619	400,309
Loans Payable
Debt Instrument [Line Items]
Long-term Debt, Total	904	2,771
Term loan
Debt Instrument [Line Items]
Long-term Debt, Total	406,937	410,125
Unamortized deferred issuance costs	$ (4,474)	$ (6,168)

Debt (Details)

Debt (Details) - USD ($)	Jul. 31, 2015	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jan. 31, 2019	Dec. 31, 2018
Credit facility
Long term debt, gross		$ 407,841,000		$ 407,841,000
Amortization of deferred financing costs				$ 2,032,000	$ 1,842,000
Excess cash flows, repayment of debt, percentage				50.00%
Excess cash flows threshold for dividends				$ 5,000,000
Term loan
Credit facility
Fair value of debt		376,400,000		376,400,000
Debt issuance costs incurred	$ 12,900,000	12,900,000		12,900,000
Deferred issuance costs, net		4,474,000		4,474,000			$ 6,168,000
Face amount	$ 425,000,000
Amortization per year (as a percent)	1.00%
Long term debt, gross		406,900,000		406,900,000
Amortization of deferred financing costs		600,000	$ 600,000	1,700,000	$ 1,800,000
Term loan | Prepayment due to Excess Cash Flow provision
Credit facility
Repayments of principal in next 12 months		0		0
Revolving loan
Credit facility
Debt issuance costs incurred	$ 1,300,000
Maximum borrowing available	$ 25,000,000					$ 12,500,000
Long term debt, gross		$ 0		$ 0
Letter-of-credit sub-facility
Credit facility
Maximum borrowing available						$ 10,000,000
Credit Facility | Alternate base rate
Credit facility
Margin of interest (as a percent)	3.75%
Credit Facility | LIBOR
Credit facility
Margin of interest (as a percent)	4.75%
Variable rate base minimum (as a percent)	1.00%

Debt - Principal Repayments (De

Debt - Principal Repayments (Details) $ in Thousands	Sep. 30, 2019USD ($)
Schedule of principal repayments under the Term Loan
2019 (remaining)	$ 1,213
2020	4,792
2021	401,836
Total	$ 407,841

Leases - Additional Information

Leases - Additional Information on Operating Leases (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2019USD ($)
Operating Lease Cost
Operating leases	$ 591	$ 1,849
Short-term lease	5	52
Total lease expense	$ 596	1,901
Cash payments included in operating cash flows		$ 1,625
Weighted average discount rate	9.33%	9.33%
Weighted average remaining lease term in years	5 years 6 months 10 days	5 years 6 months 10 days

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
Remainder of 2019	$ 540
2020	1,905
2021	1,641
2022	1,487
2023	1,277
2024 and thereafter	2,364
Total undiscounted lease payments	9,214
Less: present value adjustment	2,075
Operating lease liability	$ 7,139

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
2019	$ 3,413
2020	2,058
2021	1,790
2022	1,640
2023	1,242
Thereafter	2,396
Total	$ 12,539

Other Noncurrent Liabilities (D

Other Noncurrent Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Tax amortization benefit contingency	$ 32,363	$ 29,369
Lease liability	5,605	0
Other	2,765	2,697
Total other noncurrent liabilities	$ 40,733	$ 32,066

Severance (Details)

Severance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Compensation Related Costs [Abstract]
Severance expense	$ 0.3	$ 1.7	$ 1	$ 2.1
Severance liability, current	$ 0.6		$ 0.6		$ 1

Stockholders' Equity (Details)

Stockholders' Equity (Details)	Jul. 31, 2015directorshares	Sep. 30, 2019vote$ / sharesshares	Dec. 31, 2015shares	Dec. 31, 2018$ / sharesshares	Feb. 28, 2014shares
Class of Warrant or Right [Line Items]
Authorized common stock (in shares)		400,000,000		400,000,000
Par value of common stock (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Number of votes entitled by holders of common stock for each share of common stock | vote		1
Common stock, shares outstanding (in shares)		50,931,578		50,410,192
Number of shares issuable upon exercise of warrants (in shares)		15,983,072
Exercise price (in dollars per share) | $ / shares		$ 11.50
Number of warrants outstanding (in shares)		15,983,072
Rohm and Haas
Class of Warrant or Right [Line Items]
Number of shares of Series A Preferred Stock issued as condition to consummation of business combination (in shares)	1
Number of directors preferred stockholder is entitled to appoint if minimum ownership percentage of common stock is maintained | director	1
Minimum percentage of outstanding shares of voting and non-voting common stock to be held to entitle preferred stockholder to appoint director	10.00%
Public
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)					9,823,072
Number of warrants repurchased (in shares)			1,201,928
Private placement
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)					6,160,000

Stock-based Compensation (Detai

Stock-based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Jul. 31, 2015
Share-based Payment Arrangement [Abstract]
Shares authorized (in shares)					500,000	7,150,000
Stock-based compensation expense	$ 1	$ 0.2	$ 2.1	$ 2
Share-based compensation, nonvested awards, compensation cost not yet recognized	$ 4.4		$ 4.4
Period for recognition of compensation on unvested stock option			1 year 9 months 18 days

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Weighted Average Common Shares Outstanding (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Basic weighted-average common shares outstanding (in shares)	50,227,590	49,853,181	50,138,835	49,671,648
Effect of dilutive options, performance stock units and restricted stock (in shares)	60,714	456,798	0	0
Dilute weighted-average shares outstanding (in shares)	50,288,304	50,309,979	50,138,835	49,671,648

Earnings Per Share (Details)

Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Stock options
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,028,583	322,158	949,987	322,158
Restricted stock to non-directors
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	749,510	336,286	624,930	278,289
Warrants | Private placement
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,160,000	6,160,000	6,160,000	6,160,000
Warrants | Public
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	9,823,072	9,823,072	9,823,072	9,823,072
Director | Restricted stock to directors
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	84,427	0	72,655

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	214.00%	25.60%	28.20%	(0.80%)

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)segment	Sep. 30, 2018USD ($)
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Number of operating segments | segment			2
Number of reportable segments | segment			2
Revenues	$ 48,972	$ 68,698	$ 109,095	$ 125,470
Gross Profit	35,080	52,036	77,579	92,560
AgroFresh Core
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Revenues	45,917	64,647	96,272	112,489
Gross Profit	34,182	51,149	72,679	87,861
Tecnidex
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]
Revenues	3,055	4,051	12,823
Gross Profit	$ 898	$ 887	$ 4,900	$ 4,699

Commitment and Contingencies (D

Commitment and Contingencies (Details) $ in Millions	Oct. 14, 2019USD ($)
Unfavorable Regulatory Action | Subsequent Event
Loss Contingencies [Line Items]
Damages awarded	$ 31.1

Fair Value Measurements - Finan

Fair Value Measurements - Financial Instruments Measured on a Recurring Basis (Details) - Recurring - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Financial instruments measured at fair value on a recurring basis
Level 1 to level 2 transfers	$ 0
Transfers	0
Contingent consideration
Financial instruments measured at fair value on a recurring basis
Fair value of liability	43,770,000	$ 41,396,000
Contingent consideration | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Fair value of liability	43,207,000	40,467,000
Contingent consideration | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Fair value of liability	451,000	379,000
Contingent consideration | Liability-classified stock compensation
Financial instruments measured at fair value on a recurring basis
Fair value of liability	218,000	550,000
Contingent consideration | Level 1
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 1 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 1 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 1 | Liability-classified stock compensation
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 2
Financial instruments measured at fair value on a recurring basis
Fair value of liability	(106,000)	0
Contingent consideration | Level 2 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 2 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 2 | Liability-classified stock compensation
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0	0
Contingent consideration | Level 3
Financial instruments measured at fair value on a recurring basis
Fair value of liability	43,876,000	41,396,000
Contingent consideration | Level 3 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 43,207,000	40,467,000
Tax effect rate	21.50%
Contingent consideration | Level 3 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 451,000	379,000
Contingent consideration | Level 3 | Liability-classified stock compensation
Financial instruments measured at fair value on a recurring basis
Fair value of liability	218,000	$ 550,000
Derivative financial instruments, liabilities | Interest rate swap
Financial instruments measured at fair value on a recurring basis
Fair value of liability	(106,000)
Derivative financial instruments, liabilities | Level 1 | Interest rate swap
Financial instruments measured at fair value on a recurring basis
Fair value of liability	0
Derivative financial instruments, liabilities | Level 2 | Interest rate swap
Financial instruments measured at fair value on a recurring basis
Fair value of liability	106,000
Derivative financial instruments, liabilities | Level 3 | Interest rate swap
Financial instruments measured at fair value on a recurring basis
Fair value of liability	$ 0

Fair Value Measurements - Chang

Fair Value Measurements - Changes of Level 3 Financial Instruments (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Contingent consideration | Tax amortization benefit contingency
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	$ 40,467
Accretion	2,669
Tecnidex earnout activity	0
Stock compensation activity	0
Balance, ending period	43,207
Contingent consideration | Contingent consideration related to acquisition
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	379
Accretion	0
Tecnidex earnout activity	72
Stock compensation activity	0
Balance, ending period	451
Contingent consideration | Liability-classified stock compensation
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	550
Accretion	0
Tecnidex earnout activity	0
Stock compensation activity	(332)
Balance, ending period	218
Contingent consideration | Total
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	41,396
Accretion	2,669
Tecnidex earnout activity	72
Stock compensation activity	(332)
Balance, ending period	43,770
Derivative financial instruments, liabilities
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Mark-to-market adjustment	(35)
Derivative financial instruments, liabilities | Interest rate swap
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Mark-to-market adjustment	(106)
Term loan
Financial instruments measured at Level 3 fair value on a recurring basis
Fair value of debt	$ 376,400

Uncategorized Items - agfs-2019

Label	Element	Value
Restricted Cash and Cash Equivalents, Current	us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue	$ 527,000
Restricted Cash and Cash Equivalents, Current	us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue	$ 0